Case Study Emphasizing Severity of Harms from Nolotil Drug

2023-06-08 18:58:42

A study conducted by the Valencian Association of Hematology and Hemotherapy (AVHH), from 2004 to 2014, already confirmed how dangerous the drug is Nolotil (metamizol).

They studied 15 people who suffered the main adverse reaction of the drug: agranulocitosis. That is, decompensation in the immune system that can put the patient’s life at risk.

Most of the cases were British since it is known that people from northern Europe are more prone to suffer these damages, as we have documented with a specific case of damage by Nolotil in a british here in Spain.

Screenshot of the study we quoted.

The agranulocitosis It is a very serious complication that appears in the first 2 months of treatment, with a 20% mortalitysome of the cases in less than 24 hours.

Yes of the 15 people studied in a Valencian hospital 3 died.

It is a complication to consider not only in these northern European populations but in all people who take the treatment, of course.

As you already saw in point 4.4 of the Technical Data Sheet, this disease caused by the drug can affect anyone at any time…

And as the AVHH researchers conclude:

Photo by Karolina Grabowska.

1. Agranulocytosis secondary to drugs is a very serious complication. It is important to quickly identify and discontinue the drug that produces it.
2. Metamizole is one of the most frequently used analgesics in Spaindue to its high oral bioavailability. It has been identified as the cause of agranulocitosis, and this appears mainly in the first 2 months of treatment. There is predisposition among the population of northern Europe.

If you or a family member or acquaintance has suffered damage Contact us to review your case.

Related